Purchase Order 75N95024P00501

Award Date 8/26/24
Potential Completion Date 7/25/25
Potential Value $25K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ronkonkoma, NY 11779, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,837.60 firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The contract is for the delivery of a KNOCKIN MOUSE ES CELL LINE and has a completion date of January 11, 2024. The contract was set aside for small businesses. Ingenious Targeting Laboratory...
This federal contract award, HHSN271201600200P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $114,640 firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The contract is set aside for small businesses and supports the use of mouse knockout models to determine the function of...
This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...
This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency of the U.S. government, to Ingenious Targeting Laboratory Inc. The $9,900 purchase order contract is for the production of knockout mice from an existing embryonic stem cell line. The work supports biomedical research, which is a core part of NIDDK's mission to advance understanding and treatment of diseases like diabetes, kidney disease, and digestive...
The National Institute on Aging, a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed price purchase order contract to Biohippo Inc., a self-certified small disadvantaged business, for the construction of a custom conditional knockout mouse. The contract has a ceiling value of $24,500.00 and a period of performance ending on November 20, 2024. Biohippo Inc. has a history of providing biomedical research services and equipment to various NIH institutes, including...
This firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business, to provide services related to creating conditional knockout mice. The $24,850.00 contract was awarded by the Department of Health and Human Services (HHS) and covers activities such as generating a targeting vector and embryonic stem (ES) cells, clone screening, blastocyst injection, mouse breeding, and...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), has awarded a $7,393,450.65 firm fixed-price purchase order to Taconic Biosciences, Inc. for the operation and maintenance of a murine pathogen-free mouse breeding facility. The one-year base period, which may be extended by up to two additional one-year options, supports NIAID's intramural research programs by providing specialized genetically engineered mice,...
This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...

The National Institute on Aging (NIA), on behalf of the National Institute on Drug Abuse (NIDA), awarded a $25,098.00 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned, small disadvantaged business, for a Custom Conditional Gpnmb cDNA cassette Knockin mouse model. The purpose is to generate a Cre-inducible Gpnmb-diphtheria toxin receptor (DTR) knock-in mouse to study the role of GPNMB+ macrophages in skeletal muscle injury response and aging. The period of performance is 9-11 months. This non-competitive acquisition was conducted under simplified acquisition procedures without a set-aside designation to support biomedical research across NIH institutes.

Generated 8/27/24, 9:46 AM